[SY9] Symposium 9 : Data Science for Virology: From Models to Real-World Impact

3:50 PM - 4:15 PM JST(6:50 AM - 7:15 AM UTC)

[SY9-2] Optimal virologic endpoint selection allows efficient, rapid and small early phase trials for respiratory virus targeting antiviral agents

*Joshua T. Schiffer^1,2, Chenhui Ma¹ (1. Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, 2. Department of Medicine, University of Washington, Seattle)

Password required to view